Pediatrix Medical Group Quarterly Cash Flow Statement
NYSE: MDHealth CareHospital/Nursing ManagementUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pediatrix Medical Group free cash flow
In the quarter ended Jun 30, 2026, Pediatrix Medical Group generated $125.3 million of operating cash flow and spent $1.4 million on capital expenditures. That left free cash flow of $123.9 million, a free-cash-flow margin of 25.4% of revenue. Free cash flow was down 6.6% from the prior year's $132.7 million.
Pediatrix Medical Group returned $42.7 million to shareholders through share repurchases, equal to 34% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Pediatrix Medical Group cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 39.84M | 29.57M | 33.68M | 71.71M | 39.26M | 20.74M | 30.48M | 19.44M | -153.03M | 4.04M | -124.29M | 21.39M |
| Net Income growth (YoY) | +1.48% | +42.61% | +10.51% | +268.85% | — | +413.93% | — | -9.12% | -641.07% | -71.60% | -519.05% | -30.39% |
| Depreciation & Amortization | 5.78M | 6.12M | 5.63M | 5.55M | 5.31M | 5.33M | 6.87M | 6.25M | 8.79M | 10.31M | 9.06M | 9.21M |
| Stock-Based Compensation | 5.08M | 4.66M | 5.34M | 5.15M | 3.91M | 3.64M | 2.74M | 4.11M | 1.95M | 3.07M | 3.02M | 3.16M |
| Change in Working Capital | 61.88M | -182.13M | 53.04M | 54.70M | 71.67M | -149.50M | 91.85M | 42.17M | 60.88M | -152.65M | 32.59M | 30.40M |
| Operating Cash Flow | 125.32M | -129.85M | 114.10M | 137.28M | 137.17M | -117.46M | 133.01M | 91.84M | 106.95M | -125.23M | 69.25M | 79.94M |
| Capital Expenditures | -1.38M | -6.25M | -5.29M | -5.34M | -4.51M | -3.32M | -3.44M | -6.29M | -6.96M | -5.33M | -9.04M | -9.15M |
| Investing Cash Flow | 6.02M | -11.98M | -10.28M | 6.60M | -7.15M | -7.46M | -1.94M | -4.34M | -12.89M | -16.24M | -12.42M | -14.00M |
| Share Repurchases | -42.74M | -21.45M | -64.04M | -20.87M | -209.00K | -1.57M | -643.00K | -162.00K | -11.00K | -887.00K | 0 | -133.00K |
| Debt Issued | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Debt Repaid | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Financing Cash Flow | -48.24M | -27.64M | -68.64M | -28.56M | -4.26M | -6.04M | -4.96M | -3.07M | -82.66M | 76.20M | -4.75M | -50.60M |
| Net Change in Cash | 83.10M | -169.46M | 35.18M | 115.33M | 125.75M | -130.96M | 126.11M | 84.43M | 11.40M | -65.26M | 52.08M | 15.33M |
| Free Cash Flow | 123.94M | -136.09M | 108.81M | 131.95M | 132.65M | -120.78M | 129.57M | 85.55M | 99.99M | -130.56M | 60.21M | 70.78M |
This table shows 12 quarterly periods of Pediatrix Medical Group's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MD's reporting calendar. What is a cash flow statement?